| Literature DB >> 28191977 |
Mohammad B Haskali1, Delphine Denoyer1, Wayne Noonan1, Carleen Culinane1, Christine Rangger2, Normand Pouliot1, Roland Haubner2, Peter D Roselt1, Rodney J Hicks1, Craig A Hutton.
Abstract
Control of the biodistribution of radiolabeled peptides has proven to be a major challenge in their application as imaging agents for positron emission tomography (PET). Modification of peptide hydrophilicity in order to increase renal clearance has been a common endeavor to improve overall biodistribution. Herein, we examine the effect of site-specific sulfonation of tyrosine moieties in cyclic(RGDyK) peptides as a means to enhance their hydrophilicity and improve their biodistribution. The novel sulfonated cyclic(RGDyK) peptides were conjugated directly to 4-nitrophenyl 2-[18F]fluoropropionate, and the biodistribution of the radiolabeled peptides was compared with that of their nonsulfonated, clinically relevant counterparts, [18F]GalactoRGD and [18F]FPPRGD2. Site-specific sulfonation of the tyrosine residues was shown to increase hydrophilicity and improve biodistribution of the RGD peptides, despite contributing just 79 Da toward the MW, compared with 189 Da for both the "Galacto" and mini-PEG moieties, suggesting this may be a broadly applicable approach to enhancing biodistribution of radiolabeled peptides.Entities:
Keywords: PET imaging; RGD peptides; biodistribution; fluorine-18; sulfonation; tyrosine; tyrosine-3-sulfonate
Mesh:
Substances:
Year: 2017 PMID: 28191977 DOI: 10.1021/acs.molpharmaceut.6b01062
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 4.939